Galadriel Bonnel, Ph.D., FNP

Life-threatening emergency cases may be rare, but they can be complex. At EADV this week, experts review cases physicians should be aware of.

Potential new treatment with targeted monoclonal antibodies offers new hope for cutaneous lymphoma patients.

With immunotherapy as a key treatment for melanoma, dermatologists should be prepared to treat its cutaneous side effects and refer for adrenal sufficiency, uveitis, thyroid disease and other non-cutaneous side effects.

Checkpoint inhibitors have clearly changed the prognosis of melanoma, yet the search for evidence-based answers to these and other questions regarding their use continues, experts report at EADV this week.